Patents by Inventor Andrew J.S. Coats

Andrew J.S. Coats has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
    Patent number: 11938102
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 15, 2021
    Date of Patent: March 26, 2024
    Assignee: ACTIMED THERAPEUTICS LIMITED
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer
  • Oxprenolol compositions for treating cancer
    Patent number: 11433036
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: September 6, 2022
    Assignee: Actimed Therapeutics Limited
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer
  • S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
    Patent number: 11382876
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: April 3, 2020
    Date of Patent: July 12, 2022
    Assignee: Actimed Therapeutics LTD
    Inventors: Stefan Anker, Andrew J. S. Coats
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING MUSCLE WEAKNESS
    Publication number: 20210346320
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 19, 2021
    Publication date: November 11, 2021
    Inventors: Stefan Anker, Andrew J.S. Coats
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20210330615
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 28, 2021
    Inventors: Andrew J.S. COATS, Stefan ANKER, Jochen SPRINGER
  • S-enantiomerically enriched compositions of beta blockers for treating muscle weakness
    Patent number: 11096908
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: August 24, 2021
    Assignee: Actimed Therapeutics LTD
    Inventors: Stefan Anker, Andrew J. S. Coats
  • OXPRENOLOL COMPOSITIONS FOR TREATING CANCER
    Publication number: 20210251924
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Application
    Filed: October 7, 2020
    Publication date: August 19, 2021
    Inventors: Andrew J.S. Coats, Stefan Anker, Jochen Springer
  • S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
    Patent number: 11007158
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 18, 2019
    Date of Patent: May 18, 2021
    Assignee: ACTIMED THERAPEUTICS LIMITED
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer
  • Oxprenolol compositions for treating cancer
    Patent number: 10828270
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: November 10, 2020
    Assignee: Actimed Therapeutics Limited
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING MUSCLE WEAKNESS
    Publication number: 20200230080
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: April 3, 2020
    Publication date: July 23, 2020
    Inventors: Stefan Anker, Andrew J.S. COATS
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20200054585
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 18, 2019
    Publication date: February 20, 2020
    Inventors: Andrew J.S. COATS, Stefan ANKER, Jochen SPRINGER
  • S-enantiomerically enriched compositions of beta blockers for treating amyotrophic lateral sclerosis
    Patent number: 10449166
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 22, 2019
    Assignee: ACTIMED THERAPEUTICS LTD
    Inventors: Andrew J. S. Coats, Stefan Anker, Jochen Springer
  • Oxprenolol compositions for treating cancer
    Patent number: 10398658
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 3, 2019
    Assignee: Actimed Therapeutics Limited
    Inventors: Andrew J.S. Coats, Stefan Anker, Jochen Springer
  • OXPRENOLOL COMPOSITIONS FOR TREATING CANCER
    Publication number: 20190054043
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Application
    Filed: March 16, 2018
    Publication date: February 21, 2019
    Inventors: Andrew J.S. Coats, Stefan Anker, Jochen Springer
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING MUSCLE WEAKNESS
    Publication number: 20190046476
    Abstract: The use of S-enantiomerically enriched compositions of beta blockers for treating muscle weakness. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: February 24, 2017
    Publication date: February 14, 2019
    Inventors: Stefan Anker, Andrew J.S. COATS
  • S-ENANTIOMERICALLY ENRICHED COMPOSITIONS OF BETA BLOCKERS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS
    Publication number: 20160022613
    Abstract: The present invention relates to S-enantiomerically enriched compositions of beta blockers and uses thereof, including uses of the beta blocker compositions for treating amyotrophic lateral sclerosis. The beta blocker compositions can also be used for preventing loss of lean mass, preventing body weight loss in subjects, improving quality of life in subjects, and prolonging survival in amyotrophic lateral sclerosis patients. The beta blocker can be oxprenolol or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Andrew J.S. COATS, Stefan ANKER, Jochen SPRINGER
  • OXPRENOLOL COMPOSITIONS FOR TREATING CANCER
    Publication number: 20160022612
    Abstract: The present invention relates to compositions of S-enantiomer enriched oxprenolol and their use in treating cancer and treating or preventing, in cancer patients, cachexia, body weight loss, lean body mass loss and adipose tissue loss, and improving quality of life and prolonging survival of cancer patients.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Andrew J.S. Coats, Stefan Anker, Jochen Springer